Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram Journal Article
| Authors: | White, R. R.; Kattan, M. W.; Haney, J. C.; Clary, B. M.; Pappas, T. N.; Tyler, D. S.; Brennan, M. F. |
| Article Title: | Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram |
| Abstract: | Background: Theoretical benefits of preoperative chemoradiation therapy (preop CRT) for pancreatic cancer include improved efficacy, resectability, and patient selection. The goal of this study was to evaluate the applicability of a nomogram, which was developed for patients undergoing resection without preop CRT and which incorporates several post-resection pathological factors, to a population of patients who received preop CRT prior to resection. Methods: From 1994 to 2004, 82 patients with biopsy-proven, radiographically localized adenocarcinoma of the pancreatic head underwent preop CRT followed by pancreaticoduodenectomy (PD); 50 concurrent patients underwent PD without preop CRT. Mean nomogram-predicted disease-specific survival (DSS) rates were compared with observed DSS rates from the time of resection. Results: Despite having more locally advanced tumors on initial staging (21 vs. 8%; P < .05), patients who received preop CRT had smaller resected tumors (mean 2.3 vs. 3.1 cm; P < .01), were less likely to have T3 tumors (54 vs. 80%, P < .01), were less likely to have positive lymph nodes (29 vs. 58%, P < .01), and had fewer positive lymph nodes (mean .4 vs. 1.9, P < .01), all factors that imply treatment effect and favorably impact on nomogram-predicted DSS. Observed DSS was similar to predicted DSS in both groups. Conclusions: The similarity in observed and predicted DSS following resection in patients who received preop CRT suggests that the effects of preop CRT-whether treatment, selection, or no effect-are reflected by the nomogram. The ability of the nomogram to evaluate the effects of preop CRT on survival is limited by the potential effects of preop CRT on factors within the nomogram. © 2006 Society of Surgical Oncology. |
| Keywords: | adult; cancer survival; controlled study; middle aged; cancer surgery; survival rate; major clinical study; cisplatin; fluorouracil; advanced cancer; cancer combination chemotherapy; multimodality cancer therapy; gemcitabine; cancer radiotherapy; pancreas cancer; preoperative care; chemotherapy, adjuvant; combined modality therapy; neoadjuvant therapy; pancreatic neoplasms; radiotherapy, adjuvant; cancer staging; lymph node metastasis; preoperative evaluation; pancreaticoduodenectomy; adenocarcinoma; antineoplastic combined chemotherapy protocols; tumor biopsy; disease severity; preoperative period; nomograms; pancreas adenocarcinoma; mitomycin c; pancreatic cancer; external beam radiotherapy; nomogram; preoperative therapy; chemoradiation therapy |
| Journal Title: | Annals of Surgical Oncology |
| Volume: | 13 |
| Issue: | 11 |
| ISSN: | 1068-9265 |
| Publisher: | Springer |
| Date Published: | 2006-11-01 |
| Start Page: | 1485 |
| End Page: | 1492 |
| Language: | English |
| DOI: | 10.1245/s10434-006-9104-y |
| PUBMED: | 17013688 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 15" - "Export Date: 4 June 2012" - "CODEN: ASONF" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work